Biocon confident of accelerated growth in FY22: Kiran Mazumdar-Shaw

Biocon's Executive Chairperson Kiran Mazumdar-Shaw on the company's
plans for fresh capital infusion in Biocon Biologics, growth
opportunities in the next fiscal and why India needs to speed up covid
vaccination.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/expect-accelerated-growth-from-next-fiscal-says-kiran-mazumdar-shaw/articleshow/80442315.cms

Comments

Popular posts from this blog

Pharma Production Executive Post Vacancy @ Intas

Pharos of Chaos

HILR Intersession: Mollie Crawford-Volk: Velazquez' "Las Meninas" and its Modern Progeny